Search is Powered by Google
Breast Cancer News

Provista Life Sciences & Sonora Quest Laboratories Team Up On The BT Test(TM), A New Blood Test For Breast Cancer

Main Category: Breast Cancer
Also Included In: Cancer / Oncology
Article Date: 05 Mar 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Provista Life Sciences LLC and Sonora Quest Laboratories announced a collaborative effort that will allow doctors and patients seeking to obtain Provista Life Science's BT Test™ for breast cancer access to several strategically located Sonora Quest Laboratories phlebotomy service facilities throughout Arizona.

Provista Life Sciences, a Phoenix-based diagnostic development and commercialization company, recently announced the availability of its Biomarker Translation Test (BT Test), a blood test specifically designed to assist physicians and other healthcare providers in making an earlier and more accurate diagnosis of breast cancer when used in conjunction with mammography.

"We are thoroughly impressed with the management and staff at Sonora Quest Laboratories and their willingness to assist and support our efforts to make our BT Test more readily accessible to the public," says William J. Gartner, CEO and President of Provista Life Sciences. "Until now, doctors prescribing the test and patients wishing to take the BT Test were limited to our central Phoenix laboratory, Provista Diagnostics, for their blood draws. With Sonora Quest's support, we can now make the BT Test more readily accessible to women across all of Arizona."

Patients wanting the BT Test will need to obtain a prescription from their provider. With a prescription in hand, patients will be directed to Provista Diagnostics' Web site (http://www.ProvistaDx.com) for instruction on how to complete the ordering process, pay for the test and download a blood Draw Authorization Form. The Draw Authorization Form will direct the patients to an approved Sonora Quest Laboratories or Provista Diagnostics blood draw center. Patients who prefer not to go online, or who do not have Internet access, can go directly to Provista Diagnostics' laboratory to complete this process and have their blood drawn.

"We are extremely pleased to assist Provista Life Sciences in their efforts to make the BT Test more accessible to the women in Arizona," stated Joyce Santis, Chief Operating Officer for Sonora Quest Laboratories. "We recognize the importance of making public access as easy as possible in this regard, and we are glad we can play a role in making that happen."

About Sonora Quest Laboratories

Sonora Quest Laboratories is an integrated laboratory system servicing over 6,000 clients throughout Arizona, including hospitals, physicians, managed care organizations and employers. They have more than 2,000 employees statewide, and perform over 60,000 diagnostic tests per day. For more information, please visit http://www.sonoraquest.com.

Provista Life Sciences' Background

Provista Life Sciences was established in 2006 as a biotechnology development and commercialization organization that provides the scientific and operating management resources to rapidly advance the development and introduction of novel diagnostics technologies into the domestic and global marketplace. For more information, visit the company's Web site at http://www.provistals.com.





Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Study Of 31 Countries Finds Wide Variations In Cancer Survival Rates
18 Jul 2008
A large study published in The Lancet Oncology has found that there are wide variations in cancer survival rates between and within many countries around the world. Professor Michel Coleman (Cancer Research UK Cancer...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...